Clinical Trial

15-Hydroxyprostaglandin Dehydrogenase in Osteoarthritis and Ankylosing Spondylitis

Study acronym: HPGD-OA-AS-US
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate serum and synovial fluid 15-PGDH levels in patients with osteoarthritis and ankylosing spondylitis and determine their associations with clinical and musculoskeletal ultrasound features. To compare 15-PGDH concentrations among patients with knee osteoarthritis, and ankylosing spondylitis with knee effusion To evaluate whether serum 15-PGDH reflects intra-articular 15-PGDH concentrations. Analysis the level of 15-PGDH in relation to disease activity and severity of both diseases.
Trial Details
NCT Number NCT07751263
Lead Sponsor Assiut University
Conditions Osteoarthritis, Ankylosing Spondylitis
Enrollment 51 participants
Start Date 2026-08-02
Primary Completion 2027-08-02 (estimated)
Study Completion 2028-08-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-07